Atlas Trials

Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes

Clinical trial NCT06923488 · RECRUITING

Trial details

NCT number
NCT06923488
Sponsor
West Virginia University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2025-07-15
Primary completion
2027-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.